2018-01-25 - Unknown
901695772
| Adverse reaction report number | 901695772 |
| Latest AER version number | 0 |
| Market authorization holder AER number | CA201732284 |
| Initial received date | 2018-01-25 |
| Latest received date | 2018-01-25 |
| Age | N/A |
| Gender | Unknown |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Unknown | 40 Milligram | Narcolepsy | ||
| VYVANSE | CAPSULE | Suspect | Unknown | Product used for unknown indication |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Drug effect decreased | |
| Off label use | |